CAMBRIDGE, Mass., July 12 /CNW/ -- Mersana Therapeutics, a cancer
therapeutics company, announced today the appointment of Nicholas G.
Bacopoulos, Ph.D. to its Board of Directors. A 24-year industry veteran, Dr.
Bacopoulos brings to Mersana extensive top-level management experience in the
biopharmaceutical industry including the discovery and development of new
products in several therapeutic areas, including oncology.
